EGFR and neoplasm: To address whether poly I:C could increase the antitumor activities of CAR-T cells, mice bearing CT26-EGFRvIII or E0771-EGFRvIII tumor xenografts were treated by EGFR-targeted CAR-T cells, or their combination with poly I:C.